{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T19:57:55Z","timestamp":1792353475477,"version":"4.4.0"},"reference-count":62,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center of Excellence for Translational Neuroscience and Therapeutics","award":["Pilot grant"],"award-info":[{"award-number":["Pilot grant"]}]},{"name":"Welch Endowed Chair in Biochemistry","award":["BI-0028"],"award-info":[{"award-number":["BI-0028"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>SLC13A5 is a Na+-coupled transporter for citrate that is expressed in the plasma membrane of specific cell types in the liver, testis, and brain. It is an electrogenic transporter with a Na+:citrate3\u2212 stoichiometry of 4:1. In humans, the Michaelis constant for SLC13A5 to transport citrate is ~600 \u03bcM, which is physiologically relevant given that the normal concentration of citrate in plasma is in the range of 150\u2013200 \u03bcM. Li+ stimulates the transport function of human SLC13A5 at concentrations that are in the therapeutic range in patients on lithium therapy. Human SLC13A5 differs from rodent Slc13a5 in two important aspects: the affinity of the human transporter for citrate is ~30-fold less than that of the rodent transporter, thus making human SLC13A5 a low-affinity\/high-capacity transporter and the rodent Slc13a5 a high-affinity\/low-capacity transporter. In the liver, SLC13A5 is expressed exclusively in the sinusoidal membrane of the hepatocytes, where it plays a role in the uptake of circulating citrate from the sinusoidal blood for metabolic use. In the testis, the transporter is expressed only in spermatozoa, which is also only in the mid piece where mitochondria are located; the likely function of the transporter in spermatozoa is to mediate the uptake of citrate present at high levels in the seminal fluid for subsequent metabolism in the sperm mitochondria to generate biological energy, thereby supporting sperm motility. In the brain, the transporter is expressed mostly in neurons. As astrocytes secrete citrate into extracellular medium, the potential function of SLC13A5 in neurons is to mediate the uptake of circulating citrate and astrocyte-released citrate for subsequent metabolism. Slc13a5-knockout mice have been generated; these mice do not have any overt phenotype but are resistant to experimentally induced metabolic syndrome. Recently however, loss-of-function mutations in human SLC13A5 have been found to cause severe epilepsy and encephalopathy early in life. Interestingly, there is no evidence of epilepsy or encephalopathy in Slc13a5-knockout mice, underlining the significant differences in clinical consequences of the loss of function of this transporter between humans and mice. The markedly different biochemical features of human SLC13A5 and mouse Slc13a5 likely contribute to these differences between humans and mice with regard to the metabolic consequences of the transporter deficiency. The exact molecular mechanisms by which the functional deficiency of the citrate transporter causes epilepsy and impairs neuronal development and function remain to be elucidated, but available literature implicate both dysfunction of GABA (\u03b3-aminobutyrate) signaling and hyperfunction of NMDA (N-methyl-d-aspartate) receptor signaling. Plausible synaptic mechanisms linking loss-of-function mutations in SLC13A5 to epilepsy are discussed.<\/jats:p>","DOI":"10.3390\/molecules22030378","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T10:57:52Z","timestamp":1488279472000},"page":"378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Plasma Membrane Na+-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy"],"prefix":"10.3390","volume":"22","author":[{"given":"Yangzom","family":"Bhutia","sequence":"first","affiliation":[{"name":"Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kopel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"},{"name":"Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Neugebauer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"},{"name":"Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadivel","family":"Ganapathy","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"},{"name":"Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"ref_1","first-page":"167","article-title":"The relation between citric acid and calcium metabolism with particular reference to primary hyper-parathyroidism and idiopathic hypercalcemia","volume":"24","author":"Hodgkinson","year":"1963","journal-title":"Clin. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/jop.2011.0062","article-title":"Plasma citrate levels as a potential biomarker for glaucoma","volume":"27","author":"Fraenkl","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family\u2014Structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mam.2012.11.002","article-title":"Glucose transport families SLC5 and SLC50","volume":"34","author":"Wright","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","article-title":"Sodium-coupled monocarboxylate transporters in normal tissues and in cancer","volume":"10","author":"Ganapathy","year":"2008","journal-title":"AAPS J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2012.12.001","article-title":"SLC13 family of Na+-coupled di- and tri-carboxylate\/sulfate transporters","volume":"34","author":"Bergeron","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1126\/science.290.5499.2137","article-title":"Extended life-span conferred by cotransporter gene mutations in Drosophila","volume":"290","author":"Rogina","year":"2000","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.freeradbiomed.2014.05.015","article-title":"Caloric restriction and the aging process: A critique","volume":"73","author":"Sohal","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbabio.2015.05.005","article-title":"Dietary restriction, mitochondrial function and aging: From yeast to humans","volume":"1847","author":"Ruetenik","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e201303020","DOI":"10.5936\/csbj.201303020","article-title":"The role of INDY in metabolic regulation","volume":"6","author":"Willmes","year":"2013","journal-title":"Comput. Struct. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fgene.2015.00204","article-title":"The role of INDY in metabolism, health and longevity","volume":"6","author":"Rogers","year":"2015","journal-title":"Front. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj20021132","article-title":"Functional identity of Drosophila melanogaster Indy as a cation-independent, electroneutral transporter for tricarboxylic acid-cycle intermediates","volume":"367","author":"Inoue","year":"2002","journal-title":"Biochem. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"14315","DOI":"10.1073\/pnas.222531899","article-title":"Functional characterization and immunolocalization of the transporter encoded by the life-extending gene Indy","volume":"99","author":"Knauf","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"39469","DOI":"10.1074\/jbc.M207072200","article-title":"Structure, function, and expression pattern of novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain","volume":"277","author":"Inoue","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0006-291X(02)02669-4","article-title":"Human Na+-coupled citrate transporter: Primary structure, genomic organization, and transport function","volume":"299","author":"Inoue","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1042\/bj20031261","article-title":"Functional features and genomic organization of mouse NaCT, a sodium-coupled transporter for tricarboxylic acid cycle intermediates","volume":"378","author":"Inoue","year":"2004","journal-title":"Biochem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.114.221523","article-title":"Species-specific influence of lithium on the activity of SLC13A5 (NaCT): Lithium-induced activation is specific for the transporter in primates","volume":"353","author":"Gopal","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1471-4159.2006.03720.x","article-title":"Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons","volume":"97","author":"Yodoya","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"G402","DOI":"10.1152\/ajpgi.00371.2006","article-title":"Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines","volume":"292","author":"Gopal","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj20030827","article-title":"Human sodium-coupled citrate transporter, the orthologue of Drosophila Indy, as a novel target for lithium action","volume":"374","author":"Inoue","year":"2003","journal-title":"Biochem. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004850-199007000-00007","article-title":"Lithium and weight gain","volume":"5","author":"Chen","year":"1990","journal-title":"Int. Clin. Psycopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-979586","article-title":"Lithium and body weight gain","volume":"28","author":"Baptista","year":"1995","journal-title":"Pharmacopsychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.114.097287","article-title":"SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver","volume":"87","author":"Li","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2015.08.007","article-title":"Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes","volume":"337","author":"Schraplau","year":"2015","journal-title":"Toxicology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2337\/db13-0749","article-title":"The mammalian INDY homolog is induced by CREB in a rat model of type 2 diabetes","volume":"63","author":"Lieske","year":"2014","journal-title":"Diabetes"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Von Loeffelholz, C., Lieske, S., Neuschafer-Rube, F., Willmes, D.M., Raschzok, N., Sauer, I.M., Konig, J., Fromm, M., Horn, P., and Chatzigeorgiou, A. (2017). The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism. Hepatology, in press.","DOI":"10.1002\/hep.29089"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cmet.2011.06.009","article-title":"Deletion of the mammalian INDY homology mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice","volume":"14","author":"Birkenfeld","year":"2011","journal-title":"Cell Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.18632\/aging.100854","article-title":"Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)","volume":"7","author":"Pesta","year":"2015","journal-title":"Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"17391","DOI":"10.1038\/srep17391","article-title":"Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)","volume":"5","author":"Huard","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/acs.jmedchem.5b01752","article-title":"Optimization of a dicarboxylic series for in vivo inhibition of citrate transport by the solute carrier 13 (SLC13) family","volume":"59","author":"Huard","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(91)90268-X","article-title":"First direct demonstration of preferential release of citrate from astrocytes using [13C]NMR spectroscopy of cultured neurons and astrocytes","volume":"128","author":"Sonnewald","year":"1991","journal-title":"Neurosci. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/1566524016666151123104855","article-title":"Extracellular citrate in health and disease","volume":"15","author":"Mycielska","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajhg.2014.06.006","article-title":"Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life","volume":"95","author":"Thevenon","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1093\/brain\/awv263","article-title":"Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia","volume":"138","author":"Hardies","year":"2015","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Klotz, J., Porter, B.E., Colas, C., Schlessinger, A., and Pajor, A.M. (2016). Mutations in the Na+\/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay. Mol. Med., 22.","DOI":"10.2119\/molmed.2016.00077"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1471-4159.2012.07670.x","article-title":"Ketone bodies in epilepsy","volume":"121","author":"McNally","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00429-013-0672-x","article-title":"Monocarboxylate transporters in temporal lobe epilepsy: Roles of lactate and ketogenic diet","volume":"220","author":"Lauritzen","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00415-014-7433-5","article-title":"Focal epilepsy in glucose transporter type 1 (Glut1) defects: Case reports and a review of literature","volume":"261","author":"Wolking","year":"2014","journal-title":"J. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10545-014-9702-y","article-title":"Combined D2-\/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): Clinical course and effects of citrate treatment","volume":"37","author":"Muhlhausen","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/8904_2016_536","article-title":"Severe neonatal presentation of mitochondrial citrate carrier (SLC25A1) deficiency","volume":"30","author":"Smith","year":"2016","journal-title":"JIMD Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/psp4.12062","article-title":"Model-based assessment of plasma citrate flux into the liver: Implications for NaCT as a therapeutic target","volume":"5","author":"Li","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00216-006-0911-6","article-title":"Direct sample injection for capillary electrophoretic determination of organic acids in cerebrospinal fluid","volume":"387","author":"Ramautar","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/MCO.0b013e328312c368","article-title":"Brain energetics (thought needs food)","volume":"11","author":"Pellerin","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jnc.13630","article-title":"Aerobic glycolysis during brain activation: Adrenergic regulation and influence of norepinephrine on astrocytic metabolism","volume":"138","author":"Dienel","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1515\/hsz-2013-0271","article-title":"Citrate\u2014New functions for an old metabolite","volume":"395","author":"Iacobazzi","year":"2014","journal-title":"Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14060","DOI":"10.1073\/pnas.94.25.14060","article-title":"Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase","volume":"94","author":"Kash","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molcel.2013.07.002","article-title":"Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth","volume":"51","author":"Lin","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuropharm.2012.05.012","article-title":"Energy depletion in seizures: Anaplerosis as a strategy for future therapies","volume":"69","author":"Kovac","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1474-4422(15)00148-9","article-title":"Mitochondrial dysfunction and seizures: The neuronal energy crisis","volume":"14","author":"Zsurka","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2015.08.005","article-title":"The interneuron energy hypothesis: Implications for brain disease","volume":"90","author":"Kann","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(90)90170-B","article-title":"Seizures induced by fluoroacetic acid and fluorocitric acid may involve chelation of divalent cations in the spinal cord","volume":"179","author":"Hornfeldt","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0003-2670(01)82783-5","article-title":"Composition and stability of some metal citrate and diglycolate complexes in aqueous solution","volume":"74","author":"Field","year":"1975","journal-title":"Anal. Chim. Acta"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/ar50154a002","article-title":"Citrate conformation and chelation: Enzymic implications","volume":"13","author":"Glusker","year":"1980","journal-title":"Acc. Chem. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1523\/JNEUROSCI.17-15-05711.1997","article-title":"High-affinity zinc inhibition of NMDA NR1-NR2A receptors","volume":"17","author":"Paoletti","year":"1997","journal-title":"J. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.bpj.2011.02.042","article-title":"Zinc effects on NMDA receptor gating kinetics","volume":"100","author":"Murthy","year":"2011","journal-title":"Biophys. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.neuron.2016.11.006","article-title":"Molecular basis for subtype specificity and high-affinity zinc inhibition in the GluN1-GluN2A NMDA receptor amino-terminal domain","volume":"92","author":"Simorowski","year":"2016","journal-title":"Neuron"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1073\/pnas.92.8.3367","article-title":"Citrate modulates the regulation by Zn2+ of N-methyl-d-aspartate receptor-mediated channel current and neurotransmitter release","volume":"92","author":"Westergaard","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.neuron.2014.04.034","article-title":"Zinc dynamics and action at excitatory synapses","volume":"82","author":"Vergnano","year":"2014","journal-title":"Neuron"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-nutr-072610-145218","article-title":"Zinc in neurotransmission","volume":"31","year":"2011","journal-title":"Nutrition"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.06.008","article-title":"Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations","volume":"109","author":"Serraz","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bph.13658","article-title":"Synaptic Zn2+ and febrile seizure susceptibility","volume":"174","author":"Reid","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1085\/jgp.201411183","article-title":"A nonequilibrium binary elements-based kinetic model for benzodiazepine regulation of GABAA receptors","volume":"144","author":"Haroldson","year":"2014","journal-title":"J. Gen. Physiol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/3\/378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:29:23Z","timestamp":1760207363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/3\/378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"alternative-id":["molecules22030378"],"URL":"https:\/\/doi.org\/10.3390\/molecules22030378","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}